Jan S Moreb Selected Research

Jan S Moreb Research Topics

Disease

23	Multiple Myeloma 01/2021 - 07/2003
15	Neoplasms (Cancer) 12/2021 - 02/2008
7	Lung Neoplasms (Lung Cancer) 01/2012 - 01/2005
5	Cardiotoxicity 01/2021 - 01/2018
3	Osteoporosis 12/2021 - 02/2016
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 10/2010
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2019 - 01/2018
3	Osteonecrosis (Kienbock's Disease) 01/2019 - 02/2016
3	Drug-Related Side Effects and Adverse Reactions 01/2018 - 01/2007
3	Disease Progression 09/2017 - 05/2012
2	Leukemia 01/2019 - 01/2012
2	Hematologic Neoplasms (Hematological Malignancy) 01/2018 - 03/2016
2	Thrombocytopenia (Thrombopenia) 09/2017 - 11/2010
2	Neutropenia 09/2017 - 01/2012
2	Infections 03/2016 - 01/2011
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2008 - 03/2008
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2021
1	Heart Failure 01/2021
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2020
1	Respiratory Insufficiency (Respiratory Failure) 01/2020
1	Pathologic Complete Response 01/2018
1	Bisphosphonate-Associated Osteonecrosis of the Jaw 01/2018
1	Cytopenia 01/2018
1	Amyloidosis 11/2015
1	Squamous Cell Carcinoma of Head and Neck 09/2014
1	Inflammation (Inflammations) 09/2014
1	Bronchiolitis Obliterans Syndrome 09/2014
1	Myxoma (Myxomas) 10/2012
1	Residual Neoplasm 10/2012
1	Second Primary Neoplasms (Neoplasms, Second) 05/2012
1	Thrombophlebitis 01/2012
1	Agranulocytosis (Granulocytopenia) 01/2012
1	Infertility (Sterility) 01/2011
1	Lymphoma (Lymphomas) 01/2011
1	Obesity 10/2010

Drug/Important Bio-Agent (IBA)

6	EnzymesIBA 12/2014 - 01/2007
5	Diphosphonates (Bisphosphonates)IBA 12/2021 - 07/2014
4	carfilzomibIBA 01/2021 - 05/2018
4	Lenalidomide (CC 5013)FDA Link 01/2019 - 05/2012
3	Proteasome InhibitorsIBA 01/2021 - 05/2018
3	Aldehyde DehydrogenaseIBA 03/2009 - 07/2007
3	IsoenzymesIBA 11/2008 - 01/2005
3	Small Interfering RNA (siRNA)IBA 11/2008 - 01/2007
2	Alkylating AgentsIBA 01/2021 - 07/2003
2	Immunomodulating AgentsIBA 11/2018 - 01/2018
2	AldehydesIBA 12/2014 - 07/2007
2	Oxidoreductases (Dehydrogenase)IBA 12/2014 - 07/2007
1	lactate dehydrogenase 1 (LDH1)IBA 01/2021
1	melflufenIBA 01/2021
1	AminopeptidasesIBA 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Pyruvic Acid (Pyruvate)IBA 01/2021
1	Diphosphates (Pyrophosphates)IBA 01/2020
1	Oxi 4503IBA 01/2020
1	combretastatin A-1IBA 01/2020
1	SteroidsIBA 01/2020
1	Genetic Markers (Genetic Marker)IBA 01/2019
1	Antineoplastic Agents (Antineoplastics)IBA 01/2019
1	CD19-specific chimeric antigen receptorIBA 01/2019
1	Sirtuin 1IBA 01/2018
1	Thalidomide (Thalomid)FDA Link 01/2018
1	AntigensIBA 03/2016
1	Angiogenesis InhibitorsIBA 02/2016
1	LigandsIBA 02/2016
1	Etidronic Acid (HEDP)FDA LinkGeneric 02/2016
1	Zoledronic Acid (Zometa)FDA Link 02/2016
1	ORALIT (ORS)IBA 02/2016
1	Denosumab FDA Link 02/2016
1	TOR Serine-Threonine KinasesIBA 02/2016
1	Melphalan (Alkeran)FDA LinkGeneric 01/2016
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2015
1	Biomarkers (Surrogate Marker)IBA 12/2014
1	Proteins (Proteins, Gene)FDA Link 04/2013
1	Complex MixturesIBA 10/2012
1	Complementary DNA (cDNA)IBA 01/2012
1	Filgrastim (Neupogen)FDA Link 01/2012
1	Vancomycin FDA LinkGeneric 01/2012
1	Aztreonam FDA LinkGeneric 01/2012
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2011
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2011
1	plerixafor FDA Link 01/2011
1	VaccinesIBA 11/2010
1	Interferon-alpha (Interferon Alfa)IBA 11/2010
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 11/2010
1	SuspensionsIBA 03/2009
1	OligonucleotidesIBA 11/2008
1	CalnexinIBA 02/2008

Therapy/Procedure

14	Therapeutics 01/2020 - 11/2010
12	Stem Cell Transplantation 02/2018 - 07/2003
6	Cell Transplantation 03/2016 - 10/2010
5	Drug Therapy (Chemotherapy) 01/2018 - 07/2003
2	Immunotherapy 12/2015 - 02/2008
2	Autologous Transplantation 11/2015 - 04/2015
2	Hematopoietic Stem Cell Transplantation 09/2014 - 05/2012
1	Radiotherapy 01/2017
1	Induction Chemotherapy 01/2016
1	Catheters 01/2012
1	Oral Administration 01/2011
1	Length of Stay 01/2011